Clovis M. Kumagai

Clovis M. Kumagai

Auto-generated profile, based on publicly available information

Clovis M. Kumagai

Departamento de Ciências Farmacêuticas, Universidade Estadual de Londrina, Avenida Robert Koch, 60, Hospital Universitário, 86039-440 Londrina Paraná, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
CKClovis M. Kumagai
Clovis M. Kumagai
RMRenata Martinez
Renata Martinez
BCBarbara B. Colombo
Barbara B. Colombo
PSPriscila Saito
Priscila Saito
IPIngrid Caroline Pinto
Ingrid Caroline Pinto
Rubia CasagrandeRubia Casagrande
Rubia Casagrande
UVB radiation is certainly one of the most important environmental threats to which we are subjected to. This fact highlights the crucial protective role of the skin. However, the skin itself may not be capable of protecting against UVB depending on irradiation intensity and time of exposition. Sun blockers are used to protect our skin, but they fail to fully protect it against oxidative and inflammatory injuries initiated by UVB. To solve this issue, topical administration of active molecules is an option. 15‐Deoxy‐Δ12,14‐prostaglandin J2 (15d‐PGJ2) is an arachidonic acid‐derived lipid with proresolution and anti‐inflammatory actions. However, as far as we are aware, there is no evidence of its therapeutic use in a topical formulation to treat the deleterious events initiated by UVB, which was the aim of the present study. We used a nonionic cream to vehiculate 15d‐PGJ2 (30, 90, and 300 ng/mouse) (TFcPGJ2) in the skin of hairless mice. UVB increased skin edema, myeloperoxidase activity, metalloproteinase‐9 activity, lipid peroxidation, superoxide anion production, gp91phox and COX‐2 mRNA expression, cytokine production, sunburn and mast cells, thickening of the epidermis, and collagen degradation. UVB also diminished skin ability to reduce iron and scavenge free radicals, reduced glutathione (GSH), sulfhydryl proteins, and catalase activity. TFcPGJ2 inhibited all these pathological alterations in the skin caused by UVB. No activity was observed with the unloaded topical formulation. The protective outcome of TFcPGJ2 indicates it is a promising therapeutic approach against cutaneous inflammatory and oxidative pathological alterations.